Epidemiological Brief 25 July 2021

COVID-19 EPIDEMIOLOGICAL BRIEF Nº14-English-released

COVID-19 in Timor-Leste Epidemiological Brief 25 July 2021
Page | 1
COVID-19 in Timor-Leste
Epidemiological Brief Nº14: 19 July – 25 July 2021
A regular brief edited by: (1) Pilar 3 & Pilar 5 of the Ministry of Health (as part of the Task Force for the Prevention and
Mitigation of Covid-19 Outbreak, Integrated Centre for Crisis Management, Situation Room); (2) Instituto Nasional de Saúde;
(3) Menzies School of Health Research; (4) AUSMAT; (5) Northern Territory Centre for Disease Control; (6) CoMo Consortium;
(7) WHO.
Cumulative cases: 10,348 (220 cases since last report).
Data current as at 25 July 2021.
1. Epidemic curve
The epidemic curve shows the total case numbers for each day, in the green bars (measured
against the y-axis on the left hand side of the graph). The blue line shows the cumulative total
case numbers (measured against the y-axis on the right hand side of the graph), which have
risen now to 10,348 since the beginning of the global pandemic (as at 25 July, 2021).


2. Hospitalisations and mortality
Since 1 March 2021, there have been 253 people with COVID-19 who have required
hospitalisation. Hospitalisation numbers only include those with moderate, severe and critical
disease, who need treatment in specialised healthcare facilities for COVID-19.
This graph shows the cases that have needed hospitalisation since March 2021 in green bars.
The blue line shows the cumulative number of people who have needed hospitalisation.
There have been 26 people who have died with COVID-19. There were no deaths reported in
the last week.

COVID-19 in Timor-Leste Epidemiological Brief 25 July 2021
Page | 10
3. Incidence rate estimates
The incidence rate measures the number of confirmed cases in a population, per day, and is
usually measured as cases per 100,000 people per day. The average daily notification rate for
Timor-Leste over the past 7 days (19 July – 25 July 2021) was 2.4 cases per 100,000 population
per day, compared to 3.3 cases per 100,000 population per day in the previous reporting
period.
The national incidence rate has decreased, largely because of decreasing incidence in Dili,
where vaccination rates are high. There are concerning increases in incidence of COVID-19 in
Ermera and Viqueque.
The notification rate in all municipalities over the last 7 days is reported in the table below.

Municipality Rate per 100,000 population per
day, 12 July – 18 July 2021
Rate per 100,000 population per
day, 19 July – 25 July 2021
Aileu 0.8 1.0
Ainaro 0.0 0.0
Baucau 6.2 1.2
Bobonaro 1.6 0.4
Covalima 0.5 0.0
Dili 8.0 5.2
Ermera 1.3 4.5
Lautem 1.3 0.0
Liquica 0.2 0.0
Manatuto 0.3 0.0
Manufahi 0.0 0.0
Oecusse 0.2 0.2
Viqueque 2.3 5.2
Timor-Leste 3.3 2.4

COVID-19 in Timor-Leste Epidemiological Brief 25 July 2021
Page | 11
4. Test positivity rate
Over the last week, 4.7% (170/3.655) tests in the National Health Laboratory were positive
(compared to 5.3% in the previous reporting period).
In Baucau, 4.5% (24/528) tests were positive over the last week (compared to 8.2% in the
previous reporting period).
In Ermera, 20% (26/130) tests were positive over the last week.
In Viqueque, 16% (29/179) tests were positive over the last week.
5. Genotyping and variants of concern
In the past week, four cases of COVID-19 that were diagnosed in quarantine were
confirmed to have had the Delta variant of COVID-19. No community acquired cases
of the Delta variant of COVID-19 have been identified yet in Timor-Leste.
There is ongoing transmission of the Delta variant of COVID-19 in many countries
around the world. Transmission of Delta variant of COVID-19 has been reported in
Nusa Tengarra Timur. There is an ongoing risk of introduction of the Delta variant into
the community in Timor-Leste. Screening and testing will continue.
6. Vaccination update
As of 24 July 2021, there have been 266,622 first doses of COVID-19 vaccine given in TimorLeste, representing 35.3% of the eligible population of people aged 18 years and above.
Second doses of vaccination have commenced for those who received their first dose more
than 8 weeks ago. As of 24 July 2021, 79,217 had been given their second dose of COVID-19
vaccine in Timor-Leste, representing 10.0% of the eligible population of people aged 18 years
and above. Approximately 31% of people aged 18 years and above in Dili have received their
second dose of COVID-19 vaccine already.
People are considered fully vaccinated against COVID-19 two weeks after they receive their
second dose of a COVID-19 vaccine. People who are fully vaccinated with two doses of the
COVID-19 vaccine are at reduced risk COVID-19 infection. If someone who is fully vaccinated
gets COVID-19 they are likely to have asymptomatic or mild infection only, even if they are old
or have other comorbidities.
7. Recommendations and public health actions
It is essential that adults in Timor-Leste are vaccinated with two doses of vaccine, to prevent
a larger outbreak, especially with the threat of the Delta variant of COVID-19. If the Delta
variant of COVID-19 is introduced into the community in Timor-Leste, it is likely that it will lead
to a second peak, with large numbers of new cases. People who are fully vaccinated, with two
doses of vaccine, will have good protection against severe symptoms and death from COVID-
19, and so with vaccination it is possible to reduce the impact of a future outbreak of the Delta
variant of COVID-19.

COVID-19 in Timor-Leste Epidemiological Brief 25 July 2021
Page | 12
As well as vaccination, public health measures to reduce contact between people are
important for reducing the risk of transmission. Face masks, hand washing, physical distancing
and limiting mass gatherings of people continue to be important. The sanitary fences in place
help to reduce the risk of transmission of COVID-19 from municipalities with a high incidence,
to other parts of the country with low rates of COVID-19 currently.
Additional public health responses may be needed in Ermera and Viqueque, to address
increasing incidence of COVID-19 in these municipalities. Contact tracing and testing is
essential to help reduce further transmission.
It is important that people who are unwell with respiratory symptoms or fever seek medical
care early, especially if they have comorbidities. Do not wait to seek healthcare. Good
treatment can be provided in Ministry of Health COVID-19 treatment facilities, and the
majority of people with COVID-19 infection will recover. If people with symptoms of COVID-
19 infection stay at home and avoid medical care, there is a risk of poor outcomes including
death at home, and a risk of transmission of COVID-19 to others in the community, including
those who are most at risk.
People diagnosed with COVID-19 should comply with public health orders to isolate to protect
against the spread of COVID-19 to others.
= ENDS =

Share via
Copy link
Powered by Social Snap
COVID-19 Timor-Leste

FREE
VIEW